Get startedLog in
    Picture of Abionyx Pharma SA logo

    ABNX — Abionyx Pharma SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: ABIONYX Pharma RACERS Study In Sepsis Selected For Late-Breaking Clinical Results Poster Presentation At The ASN 2023 Annual Meeting "Kidney Week"

    Picture of Abionyx Pharma SA logoAbionyx Pharma SA
    16/10/2023 07:06
    Oct 16 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX PHARMA RACERS STUDY IN SEPSIS SELECTED FOR
LATE-BREAKING
CLINICAL RESULTS POSTER PRESENTATION AT THE AMERICAN SOCIETY OF
NEPHROLOGY (ASN) 2023 ANNUAL MEETING "KIDNEY WEEK"
    * LATE-BREAKING CLINICAL RESULTS SESSION WILL REVEAL
EXCLUSIVELY
RACERS’ PHASE 2A CLINICAL DATA IN SEPSIS THAT MET PRIMARY AND
SECONDARY ENDPOINTS

Source text for Eikon:  ID:nBwbyZHqva 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Abionyx Pharma SA

    See all news